Ameliorative potentials of Aju Mbaise extract (AME) on Dutasteride induced oxidative stress and hepatic injury in rats

Ameliorative potentials of Aju Mbaise extract (AME) on Dutasteride induced oxidative stress and hepatic injury in rats

Background & Aim: Aju Mbaise is a polyherbal extract with nutraceutical properties that helps to replenish the volume of blood lost during childbirth and improves breast milk secretion and the general wellbeing of the mother. This study evaluated the ameliorative potentials of Aju Mbaise extract...

Full description

Bibliographic Details
Main Authors:	Robert Ikechukwu Uroko, Elisha Uko Ogwo, Paul Nweje-Anyalowu, Ikenna Obiwuru, Chinomso Friday Aaron, Obinna Joseph Mba
Format:	Article
Language:	English
Published:	Islamic Azad University, Shahrekord Branch 2023-03-01
Series:	Journal of Herbal Drugs
Subjects:	dutasteride hepatic injury liver markers
Online Access:	https://jhd.shahrekord.iau.ir/issue_1136819_1138139.html

Similar Items

Protective Effects of Aju Mbaise Extract against Dutasteride-Induced Biochemical and Haematological Changes in Rats
by: Robert Ikechukwu Uroko, et al.
Published: (2022-12-01)

Ethno-botanical uses and taxonomic composition of some Aju Mbaise (Mbaise wraps)
by: C. Ekeke, et al.
Published: (2021-12-01)

Effects of dutasteride and tamsulosin on penile morphology in a rodent model
by: Marcello H. A. Da Silva, et al.
Published: (2023-06-01)

A newly modified HPLC method for estimation of dutasteride in prepared niosomes
by: Nidhal K. Maraie, et al.
Published: (2018-03-01)

Combined Anthocleista vogelii and Alstonia boonei Stem Barks Extract Alleviates Hyperlipidaemia and Renal Malfunctions in Benign Prostatic Hyperplasia-Induced Rats
by: Robert Ikechukwu Uroko, et al.
Published: (2022-10-01)

LINCS Dataset-Based Repositioning of Dutasteride as an Anti-Neuroinflammation Agent
by: Dan Luo, et al.
Published: (2021-10-01)

Is Dutasteride a Therapeutic Alternative for Amyotrophic Lateral Sclerosis?
by: Belén Proaño, et al.
Published: (2022-08-01)

Evaluation of hair regrowth after minoxidil and dutasteride tattooing in men with androgenetic alopecia
by: Sara D. Ragi, MS, et al.
Published: (2023-09-01)

Efficacy and Safety of a 5-Alpha Reductase Inhibitor, Dutasteride, Added to Bacillus Calmette-Guérin Immunotherapy for Prevention of Recurrence and Progression of Intermediate- and High-Risk Non- Muscle Invasive Bladder Cancer: A Single-Arm, Phase 2 Clinical Trial
by: Müslim Doğan Değer, et al.
Published: (2023-03-01)

CORRELATION OF THE IMPACT OF TAMSULOSIN/DUTASTERIDE COMBINATION THERAPY ON ERECTILE DYSFUNCTION (ED) IN BENIGN PROSTATIC HYPERPLASIA (BPH) IN PKU MUHAMMADIYAH GOMBONG HOSPITAL, KEBUMEN
by: Akhmad Miftahudin Fazri, et al.
Published: (2023-01-01)

Dutasteride nanoemulsion preparation to inhibit 5‐alpha‐hair follicle reductase enzymes in the hair follicle; an ex vivo study
by: Mehri Memar Bashi Aval, et al.
Published: (2023-02-01)

Improved Prostate-Specific Membrane Antigen (PSMA) Stimulation Using a Super Additive Effect of Dutasteride and Lovastatin In Vitro
by: Aleksandar Kuzmanov, et al.
Published: (2023-08-01)

Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride
by: Tina Kiguradze, et al.
Published: (2017-03-01)

Clinical, trichoscopic, and folliscopic identification of the impact of metabolic syndrome on the response to intradermal dutasteride 0.02% injection in patients with female pattern hair loss: a prospective cohort study
by: Nayera Moftah, et al.
Published: (2021-10-01)

Comparison between dutasteride and finasteride in hair regrowth and reversal of miniaturization in male and female androgenetic alopecia: a systematic review
by: Almuntaserbellah Almudaimeegh, et al.
Published: (2024-04-01)

Evaluation of phytochemicals, antioxidant contents and in vitro antioxidant activities of a combined ethanol extract of Spermacoce radiata and Hypselodelphys poggeana leaves
by: Robert Ikechukwu Uroko, et al.
Published: (2022-12-01)

Efficacy of a combination of dutasteride, tadalafil, and solifenacin in the treatment of previously unsuccessful patients
by: Kirill Kosilov, et al.
Published: (2022-01-01)

Effect of a Combination of Dutasteride and Parenteral Testosterone Undecanoate on Testosterone Deficiency Symptoms and Prostate in Patients with Testosterone Efficiency and Benign Prostatic Hyperplasia
by: Min Gu Park, et al.
Published: (2020-06-01)

Hair regrowth in endocrine therapy alopecia with dutasteride treatment in woman with estrogen positive breast cancer
by: Celina Dubin, MD, et al.
Published: (2023-05-01)

<i>In Vitro</i> Performance of Dutasteride-Nanostructured Lipid Carriers Coated with Lauric Acid-Chitosan Oligomer for Dermal Delivery
by: Norhayati Mohamed Noor, et al.
Published: (2020-10-01)

Engineered Dutasteride-Lipid Based Nanoparticle (DST-LNP) System Using Oleic and Stearic Acid for Topical Delivery
by: Norhayati Mohamed Noor, et al.
Published: (2022-01-01)

Improvement of the symptoms of lower urinary tract and sexual dysfunction with tadalafil and solifenacin after the treatment of benign prostatic hyperplasia with dutasteride
by: Kirill V. Kosilov, et al.
Published: (2020-06-01)

Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia
by: Aditya K. Gupta, et al.
Published: (2022-10-01)

Anti-oncogenic effects of dutasteride, a dual 5-alpha reductase inhibitor and a drug for benign prostate hyperplasia, in bladder cancer
by: Jaekwon Seok, et al.
Published: (2023-02-01)

Pharmacotherapy of androgenetic alopecia – a literature review
by: Marcin Tyszkiewicz, et al.
Published: (2022-11-01)

Combined Spermacoce radiata and Hypselodelphys poggeana Extract (CESH) Protect against Oxidative Stress and Enhances Haematological Parameters in Benign Prostatic Hyperplasia-induced Rats
by: Robert Ikechukwu Uroko, et al.
Published: (2022-12-01)

Use of 5-Alpha Reductase Inhibitors in Dermatology: A Narrative Review
by: Mariana Escamilla-Cruz, et al.
Published: (2023-07-01)

Negativity and Aspect in Mbaise Lect of Igbo
by: Onuoha, V. N.
Published: (2022-12-01)

Symptomatic benign prostatic hyperplasia: the role of 5-alpha-reductase inhibitors in the prevention of acute urinary retention and surgical therapy
by: Norma Marigliano, et al.
Published: (2012-01-01)

Three-Dimensional Analysis of Sex- and Gonadal Status- Dependent Microglial Activation in a Mouse Model of Parkinson’s Disease
by: Amandine Isenbrandt, et al.
Published: (2023-01-01)

Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A systematic review and continuous Bayesian network meta-analysis
by: Peter R. Feldman, et al.
Published: (2023-01-01)

EFFECTIVENESS OF 5-ALPHA-REDUCTASE INHIBITORS IN PATIENTS WITH PROSTATIC INTRAEPITHELIAL NEOPLASIA OF PERIPHERAL PROSTATE ZONE
by: M. P. Мelnychuk
Published: (2019-04-01)

Development of a Liquid Chromatography/Mass Spectrometry-Based Inhibition Assay for the Screening of Steroid 5-α Reductase in Human and Fish Cell Lines
by: Dahye Kim, et al.
Published: (2021-02-01)

Review of Adverse Drug Reactions of Medicines used for the Treatment of Benign Prostatic Hyperplasia Reported to Halmed
by: Iva Kuliš, et al.
Published: (2023-01-01)

Effect of 5-Alpha Reductase Inhibitors on Magnetic Resonance Imaging and Prostate Cancer Detection
by: Juan Morote, et al.
Published: (2024-02-01)

Nanoporous Silica Entrapped Lipid-Drug Complexes for the Solubilization and Absorption Enhancement of Poorly Soluble Drugs
by: Hey-Won Shin, et al.
Published: (2021-01-01)

Re: Effect of dutasteride on the risk of prostate cancer
by: Sooriakumaran, P, et al.
Published: (2010)

Cannabis sativa in ethanol (Monkey Tail) and tramadol induced similar degrees of toxicity in adult female Wistar rats
by: Chinomso Friday Aaron, et al.
Published: (2022-05-01)

Outcomes of dutasteride discontinuation in patients with benign prostatic hypertrophy
by: Hiroshi Masuda, et al.
Published: (2022-12-01)

Policy Implication of the Awareness and Use of Biotechnology Products Among Farmers in Aboh-Mbaise Local Government Area of Imo State, Nigeria
by: E C Matthews-Njoku, et al.
Published: (2014-12-01)